Market Overview:
The global ceramide market size reached US$ 372.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 531.9 Million by 2028, exhibiting a growth rate (CAGR) of 5.5% during 2023-2028.
Ceramides are lipids found naturally in cell membranes and composed of sphingosine alcohol with fatty acids. They aid in mediating various cellular processes affecting cell differentiation and apoptosis. As a result, they are utilized in liver steatosis, obesity-associated comorbidities, regulating inflammation, and oxidizing impaired fatty acid. Moreover, they are used as a moisturizing agent in various cosmetic and personal products to help treat different skin and hair problems caused by chronic dryness, environmental factors, aging, and skin damage.
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Ceramide Market Trends:
Individuals who suffer from eczema and psoriasis have a significant reduction of ceramides in their skin. Thus, the rising prevalence of eczema and psoriasis on account of the increasing number of people that drink and smoke represents one of the key factors catalyzing the usage of ceramides in dermatological products. In line with this, as naturally occurring ceramides decline with age, the growing geriatric population is driving the demand for ceramide-based products to improve water retention, restore the skin’s natural barrier, and reduce the visible signs of aging. Additionally, the emerging trend of vegan cosmetics is positively influencing the adoption of ceramides as they are synthetically produced without the use of animal byproducts. Besides this, as diabetes mellitus is one of the leading causes of death worldwide, there is a rise in the utilization of ceramides in the pharmaceutical industry. Furthermore, ceramides play a significant role in insulin resistance, induction of β-cell apoptosis, and the reduction of insulin gene expression, which assists in identifying potential therapeutic targets for managing diabetes mellitus and its complications. Apart from this, due to rising health consciousness among individuals, ceramides are widely being used in supplements that promote a healthier life.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global ceramide market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, process and application.
Breakup by Type:
www.imarcgroup.com
Note: Information in the above chart consists of dummy data and is only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Breakup by Process:
- Fermentation Ceramides
- Plant Extract Ceramides
Breakup by Application:
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Air Liquide S.A., Anderson Global Group LLC, Arkema S.A., Ashland Inc., Cayman Chemical Company, Croda International Plc, Evonik Industries AG, Incospharm Corporation, Jarchem Industries Inc., Kao Corporation, Toyobo Co. Ltd. and Vantage Specialty Chemicals.
Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2022 |
Historical Period |
2017-2022 |
Forecast Period |
2023-2028 |
Units |
US$ Million |
Segment Coverage |
Type, Process, Application, Region |
Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered |
Air Liquide S.A., Anderson Global Group LLC, Arkema S.A., Ashland Inc., Cayman Chemical Company, Croda International Plc, Evonik Industries AG, Incospharm Corporation, Jarchem Industries Inc., Kao Corporation, Toyobo Co. Ltd. and Vantage Specialty Chemicals. |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |